Show simple item record

dc.contributor.authorWang, Jennifer P.
dc.contributor.authorLiu, Ping
dc.contributor.authorLatz, Eicke
dc.contributor.authorGolenbock, Douglas T.
dc.contributor.authorFinberg, Robert W.
dc.contributor.authorLibraty, Daniel H.
dc.date2022-08-11T08:09:31.000
dc.date.accessioned2022-08-23T16:33:52Z
dc.date.available2022-08-23T16:33:52Z
dc.date.issued2006-11-04
dc.date.submitted2008-10-31
dc.identifier.citation<p>J Immunol. 2006 Nov 15;177(10):7114-21.</p>
dc.identifier.issn0022-1767 (Print)
dc.identifier.doi10.4049/jimmunol.177.10.7114
dc.identifier.pmid17082628
dc.identifier.urihttp://hdl.handle.net/20.500.14038/38202
dc.description.abstractTLR7 senses RNA in endosomal compartments. TLR7 expression and signaling have been demonstrated in plasmacytoid and myeloid dendritic cells, B cells, and T cells. The regulation of TLR7 signaling can play a crucial role in shaping the immune response to RNA viruses with different cellular tropisms, and in developing adjuvants capable of promoting balanced humoral and cell-mediated immunity. We used unique characteristics of two ssRNA viruses, dengue virus and influenza virus, to delineate factors that regulate viral RNA-human TLR7 signaling beyond recognition in endosomal compartments. Our data show that TLR7 recognition of enveloped RNA virus genomes is linked to virus fusion or uncoating from the endosome. The signaling threshold required to activate TLR7-type I IFN production is greater than that required to activate TLR7-NF-kappaB-IL-8 production. The higher order structure of viral RNA appears to be an important determinant of TLR7-signaling potency. A greater understanding of viral RNA-TLR7 activity relationships will promote rational approaches to interventional and vaccine strategies for important human viral pathogens.
dc.language.isoen_US
dc.relation<p><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=17082628&dopt=Abstract">Link to Article in PubMed</a></p>
dc.relation.urlhttps://doi.org/10.4049/jimmunol.177.10.7114
dc.subjectAdult
dc.subjectAnimals
dc.subjectCell Line
dc.subjectDendritic Cells
dc.subjectDengue Virus
dc.subjectDogs
dc.subjectEndosomes
dc.subjectHumans
dc.subjectHydrogen-Ion Concentration
dc.subjectInfluenza A virus
dc.subjectInterferon-alpha
dc.subjectInterleukin-8
dc.subjectMice
dc.subjectMice, Inbred C57BL
dc.subjectMice, Knockout
dc.subjectNF-kappa B
dc.subjectRNA, Viral
dc.subject*Signal Transduction
dc.subjectToll-Like Receptor 7
dc.subjectViral Fusion Proteins
dc.subjectVirus Activation
dc.subjectLife Sciences
dc.subjectMedicine and Health Sciences
dc.titleFlavivirus activation of plasmacytoid dendritic cells delineates key elements of TLR7 signaling beyond endosomal recognition
dc.typeJournal Article
dc.source.journaltitleJournal of immunology (Baltimore, Md. : 1950)
dc.source.volume177
dc.source.issue10
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/oapubs/1081
dc.identifier.contextkey659271
html.description.abstract<p>TLR7 senses RNA in endosomal compartments. TLR7 expression and signaling have been demonstrated in plasmacytoid and myeloid dendritic cells, B cells, and T cells. The regulation of TLR7 signaling can play a crucial role in shaping the immune response to RNA viruses with different cellular tropisms, and in developing adjuvants capable of promoting balanced humoral and cell-mediated immunity. We used unique characteristics of two ssRNA viruses, dengue virus and influenza virus, to delineate factors that regulate viral RNA-human TLR7 signaling beyond recognition in endosomal compartments. Our data show that TLR7 recognition of enveloped RNA virus genomes is linked to virus fusion or uncoating from the endosome. The signaling threshold required to activate TLR7-type I IFN production is greater than that required to activate TLR7-NF-kappaB-IL-8 production. The higher order structure of viral RNA appears to be an important determinant of TLR7-signaling potency. A greater understanding of viral RNA-TLR7 activity relationships will promote rational approaches to interventional and vaccine strategies for important human viral pathogens.</p>
dc.identifier.submissionpathoapubs/1081
dc.contributor.departmentCenter for Infectious Disease and Vaccine Research
dc.contributor.departmentDepartment of Medicine, Division of Infectious Diseases and Immunology
dc.source.pages7114-21


This item appears in the following Collection(s)

Show simple item record